X-Linked Adrenoleukodystrophy

Disease Overview

X-Linked Adrenoleukodystrophy (X-ALD) is a rare genetic disorder characterized by the progressive accumulation of very long-chain fatty acids (VLCFAs) in the body, leading to neurological and endocrine dysfunction. The disorder primarily affects the nervous system, adrenal glands, and white matter of the brain.

Disease Category

Genetic Disorder Metabolic Disorder Neurological Disorder X-Linked Inherited Condition

Synonyms

Adrenomyeloneuropathy (AMN)
Siemerling-Creutzfeldt Disease
Schilder's Disease
X-ALD

Signs & Symptoms

Neurological Symptoms: - Progressive demyelination - Cognitive decline - Seizures - Vision and hearing impairment - Muscle weakness - Coordination difficulties - Peripheral neuropathy

Endocrine Symptoms: - Adrenal insufficiency - Hormonal imbalances - Addison's disease-like symptoms

Psychological Symptoms: - Behavioral changes - Learning difficulties - Developmental regression

Causes

Genetic Mechanism: - Mutations in the ABCD1 gene located on the X chromosome - Impaired function of the ALDP (adrenoleukodystrophy protein) - Inability to break down very long-chain fatty acids - X-linked recessive inheritance pattern

Affected Populations

Primarily affects males
Carrier females may exhibit mild symptoms
Estimated prevalence: 1 in 17,000 male births
Onset can range from early childhood to adulthood

Disorders with Similar Symptoms

Multiple Sclerosis
Addison's Disease
Hereditary Spastic Paraplegia
Other Leukodystrophies
Cerebral Palsy
Mitochondrial Disorders

Diagnosis

Diagnostic Approaches: - Comprehensive medical history - Physical examination - Blood tests measuring VLCFA levels - Genetic testing for ABCD1 mutations - Adrenal function tests - Brain and spinal MRI - Neurological assessments - Nerve conduction studies

Standard Therapies

Treatment Options: - Lorenzo's Oil to potentially slow VLCFA accumulation - Adrenal hormone replacement therapy - Hematopoietic stem cell transplantation (HSCT) - Physical and occupational therapy - Symptomatic management - Nutritional support - Psychological counseling

Clinical Trials and Studies

Current research focuses on: - Gene therapy - Enzyme replacement strategies - Advanced stem cell treatments - Molecular mechanisms of VLCFA accumulation

References

National Institutes of Health (NIH)
Genetics Home Reference
Journal of Inherited Metabolic Disease
American Journal of Medical Genetics

Programs & Resources

United Leukodystrophy Foundation (ULF)
The Myelin Project
ALD Connect
National Organization for Rare Disorders (NORD)
Genetic Support Foundation

Complete Report

A comprehensive medical report should be obtained through specialized genetic and neurological consultations, including detailed genetic counseling and long-term management strategies.